Acinetobacter baumannii is a Gram-negative microorganism and a member of the ESKAPE pathogen group. It poses a significant threat to public health due to its association with nosocomial infections and high mortality rates. In recent years, there has been an increasing emergence of multidrug-resistant strains, a phenomenon linked to the misuse and overuse of antibiotics, including their use in livestock farming.
This study aims to provide a detailed description of the resistance mechanisms in Acinetobacter baumannii against tetracyclines, beta-lactams, aminoglycosides, and fluoroquinolones.
To achieve these aims, we conducted a literature review of scientific articles published in PubMed and Google Scholar.
The development of resistance in Acinetobacter baumannii is associated with alterations in cell membrane permeability, the presence of efflux pumps, protection of antibiotic targets within the bacterial cell, and direct inactivation of antibiotics. Understanding the resistance mechanisms of Acinetobacter baumannii and other ESKAPE pathogens is crucial for safeguarding public health.
Howard A, O’Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii. Virulence. 2012 May 27;3(3):243–50.
O’Shea MK. Acinetobacter in modern warfare. Int J Antimicrob Agents. 2012 May;39(5):363–75.
Ma C, McClean S. Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It. Vaccines (Basel). 2021 Jun 1;9(6).
Mohd Sazlly Lim S, Zainal Abidin A, Liew SM, Roberts JA, Sime FB. The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis. Journal of Infection. 2019 Dec;79(6):593–600.
Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii Antibiotic Resistance Mechanisms. Pathogens. 2021 Mar 19;10(3):373.
The structure of β-lactamases. Philosophical Transactions of the Royal Society of London B, Biological Sciences. 1980 May 16;289(1036):321–31.
Higgins PG, Pérez-Llarena FJ, Zander E, Fernández A, Bou G, Seifert H. OXA-235, a Novel Class D β-Lactamase Involved in Resistance to Carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2013 May;57(5):2121–6.
Périchon B, Goussard S, Walewski V, Krizova L, Cerqueira G, Murphy C, et al. Identification of 50 Class D β-Lactamases and 65 Acinetobacter-Derived Cephalosporinases in Acinetobacter spp. Antimicrob Agents Chemother. 2014 Feb;58(2):936–49.
Kyriakidis I, Vasileiou E, Pana ZD, Tragiannidis A. Acinetobacter baumannii Antibiotic Resistance Mechanisms. Pathogens. 2021 Mar 19;10(3):373.
Lin MF. Antimicrobial resistance in Acinetobacter baumannii : From bench to bedside. World J Clin Cases. 2014;2(12):787.
Kaderabkova N, Bharathwaj M, Furniss RCD, Gonzalez D, Palmer T, Mavridou DAI. The biogenesis of β-lactamase enzymes. Microbiology (N Y). 2022 Sep 22;168(8).
Wu W, Feng Y, Tang G, Qiao F, McNally A, Zong Z. NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings. Clin Microbiol Rev. 2019 Mar 20;32(2).
Wu HJ, Xiao ZG, Lv XJ, Huang HT, Liao C, Hui CY, et al. Drug resistant Acinetobacter baumannii : From molecular mechanisms to potential therapeutics (Review). Exp Ther Med. 2023 Mar 23;25(5):209.
Jacoby GA. AmpC β-Lactamases. Clin Microbiol Rev. 2009 Jan;22(1):161–82.
Said HS, Benmahmod AB, Ibrahim RH. Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt. World J Microbiol Biotechnol. 2018 Dec 3;34(12):189.
Wu HJ, Xiao ZG, Lv XJ, Huang HT, Liao C, Hui CY, et al. Drug resistant Acinetobacter baumannii : From molecular mechanisms to potential therapeutics (Review). Exp Ther Med. 2023 Mar 23;25(5):209.
Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN. Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep. 2021 Oct 30;48(10):6987–98.
Shi X, Wang H, Wang X, Jing H, Duan R, Qin S, et al. Molecular characterization and antibiotic resistance of Acinetobacter baumannii in cerebrospinal fluid and blood. PLoS One. 2021 Feb 22;16(2):e0247418.
Jyothisri K, Deepak V, Rajeswari MR. Purification and characterization of a major 40 kDa outer membrane protein of Acinetobacter baumannii. FEBS Lett. 1999 Jan 22;443(1):57–60.
Zhong X, Wu X, Schweppe DK, Chavez JD, Mathay M, Eng JK, et al. In Vivo Cross-Linking MS Reveals Conservation in OmpA Linkage to Different Classes of β-Lactamase Enzymes. J Am Soc Mass Spectrom. 2020 Feb 5;31(2):190–5.
Zhu L, Chen X, Hou P. Mutation of CarO participates in drug resistance in imipenem‐resistant Acinetobacter baumannii. J Clin Lab Anal. 2019 Oct 18;33(8).
Magnet S, Courvalin P, Lambert T. Resistance-Nodulation-Cell Division-Type Efflux Pump Involved in Aminoglycoside Resistance in Acinetobacter baumannii Strain BM4454. Antimicrob Agents Chemother. 2001 Dec;45(12):3375–80.
Vila J, Martí S, Sánchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. 2007 Jun 1;59(6):1210–5.
Marchand I, Damier-Piolle L, Courvalin P, Lambert T. Expression of the RND-Type Efflux Pump AdeABC in Acinetobacter baumannii Is Regulated by the AdeRS Two-Component System. Antimicrob Agents Chemother. 2004 Sep;48(9):3298–304.
Yoon EJ, Nait Chabane Y, Goussard S, Snesrud E, Courvalin P, Dé E, et al. Contribution of Resistance-Nodulation-Cell Division Efflux Systems to Antibiotic Resistance and Biofilm Formation in Acinetobacter baumannii. mBio. 2015 May;6(2).
Sheikhalizadeh V, Hasani A, Ahangarzadeh Rezaee M, Rahmati-yamchi M, Hasani A, Ghotaslou R, et al. Comprehensive study to investigate the role of various aminoglycoside resistance mechanisms in clinical isolates of Acinetobacter baumannii. Journal of Infection and Chemotherapy. 2017 Feb;23(2):74–9.
Jana S, Deb JK. Molecular understanding of aminoglycoside action and resistance. Appl Microbiol Biotechnol. 2006 Mar 1;70(2):140–50.
Warburton PJ, Amodeo N, Roberts AP. Mosaic tetracycline resistance genes encoding ribosomal protection proteins. Journal of Antimicrobial Chemotherapy. 2016 Dec;71(12):3333–9.
Xu CF, Bilya SR, Xu W. adeABC efflux gene in Acinetobacter baumannii. New Microbes New Infect. 2019 Jul;30:100549.
Yuhan Y, Ziyun Y, Yongbo Z, Fuqiang L, Qinghua Z. Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae. Rev Soc Bras Med Trop. 2016 Apr;49(2):165–71.
Foong WE, Wilhelm J, Tam HK, Pos KM. Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters. Journal of Antimicrobial Chemotherapy. 2020 May 1;75(5):1135–9.
Ribera A, Ruiz J, Vila J. Presence of the Tet M Determinant in a Clinical Isolate of Acinetobacter baumannii. Antimicrob Agents Chemother. 2003 Jul;47(7):2310–2.
Yuhan Y, Ziyun Y, Yongbo Z, Fuqiang L, Qinghua Z. Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae. Rev Soc Bras Med Trop. 2016 Apr;49(2):165–71.
Foong WE, Wilhelm J, Tam HK, Pos KM. Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters. Journal of Antimicrobial Chemotherapy. 2020 May 1;75(5):1135–9.
Su XZ, Chen J, Mizushima T, Kuroda T, Tsuchiya T. AbeM, an H + -Coupled Acinetobacter baumannii Multidrug Efflux Pump Belonging to the MATE Family of Transporters. Antimicrob Agents Chemother. 2005 Oct;49(10):4362–4.
Mohammed MA, Salim MTA, Anwer BE, Aboshanab KM, Aboulwafa MM. Impact of target site mutations and plasmid associated resistance genes acquisition on resistance of Acinetobacter baumannii to fluoroquinolones. Sci Rep. 2021 Oct 11;11(1):20136.
Vrancianu CO, Gheorghe I, Czobor IB, Chifiriuc MC. Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii. Microorganisms. 2020 Jun 21;8(6):935.
Nogbou ND, Nkawane GM, Ntshane K, Wairuri CK, Phofa DT, Mokgokong KK, et al. Efflux Pump Activity and Mutations Driving Multidrug Resistance in Acinetobacter baumannii at a Tertiary Hospital in Pretoria, South Africa. Int J Microbiol. 2021 Oct 7;2021:1–12.
